BofA raised the firm’s price target on Alignment Healthcare (ALHC) to $13 from $11 and keeps a Buy rating on the shares after outperformance in Q3 on revenue growth, SG&A leverage, and absolute profit ...

In recent trading, shares of Alignment Healthcare Inc (Symbol: ALHC) have crossed above the average analyst 12-month target price of $16.41, changing hands for $16.74/share. When a stock reaches the ...

TD Cowen analyst Gary Taylor raised the firm’s price target on Alignment Healthcare (ALHC) to $13 from $10 and keeps a Buy rating on the shares. The firm are updating its model following 3Q24 results.

Piper Sandler raised the firm’s price target on Alignment Healthcare (ALHC) to $21 from $14 and keeps an Overweight rating on the shares. The Alignment flywheel is gaining momentum across states, the ...

For Q4, Alignment expects "health plan membership to be between 232,500 and 234,500 members, revenue to be in the range of $995 million to $1.01 billion; adjusted gross profit to be between $104 ...